Stocks & ETFunds

Cannabis stocks are down 20%, on average, YTD but there are 11 stocks in munKNEE.com's Pot Stock Index that are UP 35.8%, on average, YTD, This article identifies these hidden gems and how well they have done over the past 7 months.

We are at the point of true risk/reward in the Silver and Gold markets so it is time to take advantage of the situation,

Some investors might not be aware that SPDR Gold Trust (GLD) does not, in ordinary circumstances, allow for the redemption of physical gold while the Sprott Physical Gold Trust (PHYS) has the unique property of allowing investors to trade in their shares for physical gold deliveries. This article takes a look at the performance, liquidity and purpose of each to determine which is best under which circumstances.

The 11 publicly traded "marijuana" ETFs (listed below) include a large percentage of pharmaceutical, real estate, grower supply, and tobacco/spirit companies. Why is that?

IF the bull market in stocks and bonds is to end, the implications will be dire because, historically, the Fed has always intervened to prop the market by lowering interest rates. Fed moves impact the broader market equities and impact resource equities alike so let’s take a look at the effect of a general market correction on our resource portfolio.

When it comes to valuing stocks, the price-to-earnings (P/E) ratio is the number one metric for investors that want an instant fix on what the market thinks of a company. [That being said]...there are health warnings to heed if you don’t want to be left exposed by its limitations. [Let me explain.] Words: 1101

A month ago I wrote that, with the non-penny cannabis stock sector advancing significantly for 2 months in a row (+11% in April and +25.3% in May), it might well be suggesting that the sector had finally hit bottom at the end of March but the -8.0% performance in June shows it to be a "2 steps forward and 1 step back" situation.

Only 6 pure-play non-penny pot stocks are UP year-to-date out of a total of 300 actively traded cannabis stocks listed on the various North American stock exchanges. These "momentum" stocks, representing just 2% of the total, suggest that their companies are well managed, well financed and executing their respective business plans in such a manner as to have the confidence of serious marijuana stock investors. As such, they deserve your attention and this article does just that.

Below is the June performance of the constituents of the equally-weighted Non-penny Pot Stock Index (NPSI) of 25 pure-play cannabis stocks within each of the 3 categories that represent their primary area of focus in the cannabis industry.

7 major consumer and pharmaceutical corporations have bought into marijuana companies to take full advantage of this rapidly growing market and this article compares their stock performance YTD compared with that of their marijuana partners: